This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Cramer's 'Stop Trading!': Merger Mania

NEW YORK ( TheStreet) -- With an 11% jump in new-home sales in June, Jim Cramer's eyes are on Centex (CTX), he said on Monday's "Stop Trading!" segment on CNBC.

Pulte's (PHM - Get Report) deal to buy Centex will close in August, which will be "monumental." He said the "whole group's been on a tear," but with the catalyst of the closing of the Pulte deal, Centex is where he'd put his money.

Cramer called Capital One (COF - Get Report) "a battleground" and advised viewers that, after its "big leap back to $30," it would likely pull back "before it has its next one."

Cramer said that recent acquisitions -- including Bristol-Myers' (BMY), Johnson & Johnson's (JNJ - Get Report) and First Niagara's (FNFG - Get Report) -- "are very good." "I think that people should start recognizing that when your stock goes up after a deal, when people see this, it bring more and more mergers," he said.

Cramer said that had Eaton (ETN - Get Report) reported today, "I think it would've barely gone up." He said the stock is now "very overbought" and recommended waiting for a pullback to buy. "Eaton has been one of my favorites for a long time," he said, but "not up here. I don't want to buy it in the $50s."

--Rebecca Corvino writes from New York.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CTX $26.61 0.00%
BMY $65.67 0.00%
COF $78.65 0.00%
ETN $69.65 0.00%
FNFG $8.77 0.00%


DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs